Page last updated: 2024-09-05

antalarmin and nbi-34041

antalarmin has been researched along with nbi-34041 in 2 studies

Compound Research Comparison

Studies (antalarmin)	Trials (antalarmin)	Recent Studies (post-2010) (antalarmin)	Studies (nbi-34041)	Trials (nbi-34041)	Recent Studies (post-2010) (nbi-34041)
181	0	76	5	1	1

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, TK; Crowe, PD; Dyck, B; Grey, J; Grigoriadis, DE; Gross, RS; Guo, Z; Haddach, M; Kiankarimi, M; Lanier, M; Li, BF; Luo, Z; McCarthy, JR; Moorjani, M; Saunders, J; Sullivan, R; Tellew, JE; Williams, JP; Zamani-Kord, S; Zhang, X	1
Bu, JH; Chen, T; Coon, T; Crowe, PD; Dyck, B; Grigoriadis, DE; Gross, RS; Guo, Z; Haddach, M; Hoare, SR; Huang, CQ; Lowe, RF; Marinkovic, D; McCarthy, J; Moorjani, M; Nelson, J; Saunders, J; Sullivan, R; Williams, JP; Zamani-Kord, S	1

Other Studies

2 other study(ies) available for antalarmin and nbi-34041

Article	Year
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists. Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16 Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Blood-Brain Barrier; CHO Cells; Corticotropin-Releasing Hormone; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Injections, Intravenous; Male; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship	2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. Journal of medicinal chemistry, 2005, Sep-08, Volume: 48, Issue:18 Topics: Acenaphthenes; Adrenocorticotropic Hormone; Animals; Cells, Cultured; Corticotropin-Releasing Hormone; Cyclic AMP; Drug Design; Female; Heterocyclic Compounds, 3-Ring; Humans; Molecular Conformation; Pituitary Gland, Anterior; Pyrazoles; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship	2005

Article

Year

Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists.

Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16

Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Blood-Brain Barrier; CHO Cells; Corticotropin-Releasing Hormone; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Injections, Intravenous; Male; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship

2005

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.

Journal of medicinal chemistry, 2005, Sep-08, Volume: 48, Issue:18

Topics: Acenaphthenes; Adrenocorticotropic Hormone; Animals; Cells, Cultured; Corticotropin-Releasing Hormone; Cyclic AMP; Drug Design; Female; Heterocyclic Compounds, 3-Ring; Humans; Molecular Conformation; Pituitary Gland, Anterior; Pyrazoles; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship

2005